Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Clinical trial NCT00712491 · TERMINATED

Trial details

NCT number: NCT00712491
Sponsor: Santen Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Age-related Macular Degeneration Choroidal Neovascularization

Start date: 2008-09-01
Primary completion: 2009-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.